meningococcal (groups A, C, Y, W) diphtheria toxoid conjugate vaccine
Trade name: Menactra
Vaccineapproved
Approved
Jan 14, 2005
Clinical trial activity
28 trials · 1 clinical orgs · 1 marketing orgs
Phase 1
0
Phase 2
28
Phase 3
21
Phase 4
0
Earliest trial started Feb 1, 2007 (NCT00390143)
Timeline
2000s
- Jan 14, 2005
Sanofi-Aventis — Earliest FDA Approval
- Jan 14, 2005
Sanofi-Aventis — NDA Organization
- Jan 1, 2007
Earliest Phase 2 Sponsor(trial)
- Jan 1, 2007
Earliest Phase 3 Sponsor(trial)
Indications
Approved for
Mechanism of action
- Neisseria meningitidisImmunity, active
Neisseria meningitidis immunity, active
Approval history
- approvedJan 14, 2005
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- gsk134612
- gsk 134612
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01934140 | Phase 3 | Apr 1, 2014 | GlaxoSmithKline |
| NCT01939158 | Phase 3 | Oct 2, 2013 | GlaxoSmithKline |
| NCT01962207 | Phase 3 | Oct 1, 2013 | GlaxoSmithKline |
| NCT01777308 | Phase 3 | May 1, 2013 | GlaxoSmithKline |
| NCT01767376 | Phase 3 | Jan 10, 2013 | GlaxoSmithKline |
| NCT01755689 | Phase 3 | Jan 1, 2013 | GlaxoSmithKline |
| NCT01641042 | Phase 3 | Sep 1, 2012 | GlaxoSmithKline |
| NCT01340898 | Phase 3 | Jan 1, 2012 | GlaxoSmithKline |
| NCT01235975 | Phase 3 | Nov 1, 2010 | GlaxoSmithKline |
| NCT01165242 | Phase 2 | Aug 19, 2010 | GlaxoSmithKline |
| NCT01154088 | Phase 3 | Aug 1, 2010 | GlaxoSmithKline |
| NCT01144663 | Phase 3 | Jul 1, 2010 | GlaxoSmithKline |
| NCT00955682 | Phase 3 | Aug 1, 2009 | GlaxoSmithKline |
| NCT00758264 | Phase 3 | Oct 1, 2008 | GlaxoSmithKline |
| NCT00718666 | Phase 2 | Oct 1, 2008 | GlaxoSmithKline |
| NCT00674583 | Phase 3 | May 1, 2008 | GlaxoSmithKline |
| NCT00661557 | Phase 2 | May 1, 2008 | GlaxoSmithKline |
| NCT00614614 | Phase 3 | Feb 1, 2008 | GlaxoSmithKline |
| NCT00514904 | Phase 3 | Sep 1, 2007 | GlaxoSmithKline |
| NCT00508261 | Phase 3 | Aug 1, 2007 | GlaxoSmithKline |
Showing 20 of 28 trials
Page 1 / 2
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| GlaxoSmithKline | For profit | 28 | 28 | 2 | 2007 |
1 organizations
Page 1 / 1
Marketing (1)
| Organization | Org type | Relationship | Date |
|---|---|---|---|
| Sanofi-Aventis | For profit | NDA | Jan 14, 2005 |